Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 062170

Expand all

KLEBCIL (KANAMYCIN SULFATE)
EQ 75MG BASE/2ML
Marketing Status: Discontinued

Active Ingredient: KANAMYCIN SULFATE
Proprietary Name: KLEBCIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 75MG BASE/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062170
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: KING PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

KLEBCIL (KANAMYCIN SULFATE)
EQ 500MG BASE/2ML
Marketing Status: Discontinued

Active Ingredient: KANAMYCIN SULFATE
Proprietary Name: KLEBCIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062170
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: KING PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

KLEBCIL (KANAMYCIN SULFATE)
EQ 1GM BASE/3ML
Marketing Status: Discontinued

Active Ingredient: KANAMYCIN SULFATE
Proprietary Name: KLEBCIL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/3ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A062170
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: KING PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information